Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Syed Naqvi

TitleAssistant Professor
InstitutionUniversity of Arkansas for Medical Sciences
DepartmentCOM | Internal Med Hem-Onc
Address4301 W Markham
Little Rock AR 72205
ORCID ORCID Icon0009-0002-2946-512X Additional info
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions. Don't see publications published under other names? Login to add alternative names.
    List All   |   Timeline
    1. Sabol HM, Anloague A, Kaur J, Bustamante-Gomez C, Khan S, Paxton BC, Nester MR, Hackney J, Diaz-delCastillo M, Mann D, Stambough JB, Barnes CL, Ambrogini E, Frontier A, Ebetino FH, Naqvi S, van Rhee F, Wardell CP, Drake MT, Nookaew I, Schinke C, Zangari M, Delgado-Calle J. Healing of lytic lesions and restoration of bone health in multiple myeloma through sclerostin inhibition. Exp Hematol Oncol. 2025 Aug 22; 14(1):108. PMID: 40847323.
      View in: PubMed
    2. Maraka S, Owen RR, Singh Ospina NM, Knox M, Dodds T, Thostenson JD, Dishongh K, Raciborski RA, Albashaireh A, Shah A, Syed S, Naqvi S, Motahari H, Thumma S, Toloza F, Ambrogini E, Brito JP. Discontinuation of levothyroxine therapy in patients with subclinical hypothyroidism: a pilot randomized clinical trial. Endocrine. 2025 Jul 30. PMID: 40736623.
      View in: PubMed
    3. DePalo DK, Dugan MM, Naqvi SMH, Ollila DW, Hieken TJ, Block MS, van Houdt WJ, Wouters MWJM, Reijers SJM, Asher N, Broman KK, Duncan Z, Anderson M, Gyorki DE, Snow H, Held J, Farma JM, Vetto JT, Hui JYC, Kolbow M, Saw RPM, Lo SN, Long GV, Thompson JF, Kim Y, Karapetyan L, Ny L, van Akkooi ACJ, Olofsson Bagge R, Zager JS. A comparison of isolated limb infusion/perfusion, immune checkpoint inhibitors, and intralesional therapy as first-line treatment for patients with melanoma in-transit metastases. Cancer. 2025 Jan 01; 131(1):e35636. PMID: 39522025.
      View in: PubMed
    4. Vince M, Naqvi SMH, Pellini B, Verbosky M, Melzer D. Real-world comparison of the efficacy and safety of atezolizumab versus durvalumab in extensive-stage small cell lung cancer. Lung Cancer. 2024 Dec; 198:107999. PMID: 39500124.
      View in: PubMed
    5. Aflatooni S, Dugan MM, Boby A, Ghali H, DePalo DK, Naqvi SMH, Mullinax JE, Zager JS. Isolated Limb Infusion for Limb-Threatening Sarcomas. Ann Surg Oncol. 2024 Dec; 31(13):9272-9280. PMID: 39256312.
      View in: PubMed
    6. Naqvi S, Shrestha A, Alzubi M, Alrawabdeh J, Thanendrarajan S, Zangari M, van Rhee F, Schinke C, Al Hadidi S. Weight loss and dysgeusia in relapsed/refractory multiple myeloma patients treated with talquetamab. EJHaem. 2024 Aug; 5(4):789-792. PMID: 39157593.
      View in: PubMed
    7. Menon LP, Naqvi S, Maradana J, Edem D. Recurrent Graves' Disease Following Near-Total Thyroidectomy: A Case Report and Literature Review. Cureus. 2024 Jan; 16(1):e52260. PMID: 38352081.
      View in: PubMed
    8. Carr MJ, Sun J, DePalo D, Rothermel LD, Song Y, Straker RJ, Baecher K, Louie RJ, Stahlie EHA, Wright GP, Naqvi SMH, Kim Y, Sarnaik AA, Karakousis GC, Lowe MC, Delman KA, van Akkooi ACJ, Ollila DW, Collichio F, Zager JS. Talimogene Laherparepvec (T-VEC) for the Treatment of Advanced Locoregional Melanoma After Failure of Immunotherapy: An International Multi-Institutional Experience. Ann Surg Oncol. 2022 Feb; 29(2):791-801. PMID: 34648098.
      View in: PubMed
    9. Broman KK, Hughes T, Dossett L, Sun J, Kirichenko D, Carr MJ, Sharma A, Bartlett EK, Nijhuis AAG, Thompson JF, Hieken TJ, Kottschade L, Downs J, Gyorki DE, Stahlie E, van Akkooi A, Ollila DW, Frank J, Song Y, Karakousis G, Moncrieff M, Nobes J, Vetto J, Han D, Farma JM, Deneve JL, Fleming MD, Perez MC, Lowe MC, Olofsson Bagge R, Mattsson J, Lee AY, Berman RS, Chai H, Kroon HM, Teras J, Teras RM, Farrow NE, Beasley G, Hui JYC, Been L, Kruijff S, Kim Y, Naqvi SMH, Sarnaik AA, Sondak VK, Zager JS. Active surveillance of patients who have sentinel node positive melanoma: An international, multi-institution evaluation of adoption and early outcomes after the Multicenter Selective Lymphadenectomy Trial II (MSLT-2). Cancer. 2021 07 01; 127(13):2251-2261. PMID: 33826754.
      View in: PubMed
    10. Carr MJ, Sun J, Kroon HM, Miura JT, Beasley GM, Farrow NE, Mosca PJ, Lowe MC, Farley CR, Kim Y, Naqvi SMH, Kirichenko DA, Potdar A, Daou H, Mullen D, Farma JM, Henderson MA, Speakman D, Serpell J, Delman KA, Smithers BM, Coventry BJ, Tyler DS, Thompson JF, Zager JS. Oncologic Outcomes After Isolated Limb Infusion for Advanced Melanoma: An International Comparison?of the Procedure and Outcomes Between the United States and Australia. Ann Surg Oncol. 2020 Dec; 27(13):5107-5118. PMID: 32918177.
      View in: PubMed
    11. Sandoval-Sus JD, Chavez JC, Dalia S, Naqvi SMH, Talati C, Nodzon L, Kharfan-Dabaja MA, Pinilla-Ibarz J. Association between immunoglobulin heavy-chain variable region mutational status and isolated favorable baseline genomic aberrations in chronic lymphocytic leukemia. Leuk Lymphoma. 2018 01; 59(1):59-68. PMID: 28641468.
      View in: PubMed
    Naqvi's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    See all (45) concept(s)
    _
    Co-Authors Expand Description
    See all (14) people
    _
    Similar People Expand Description
    See all (29) people
    _
    Same Department Expand Description
    Search Department